The NIH’s Data on Ivermectin and FDA’s Statement on HCQ

The NIH and FDA has neutral rulings on Ivermectin and HCQ. It was similar statements they said for Regeneron and Lily Antibodies. Covid Uncovered: Dr. Peter McCullough.

What does one of the most widely-published, peer-reviewed doctors in the world treating Covid-19 recommend?

‘A Guide to Home-based COVID treatment’ here:

https://aapsonline.org/CovidPatientTreatmentGuide.pdf

Who is Dr. Peter McCullough?
Internist, cardiologist, epidemiologist, Dr. McCullough is the most published physician in the world on cardiovascular illness and renal disease with over 1,000 publications and over 600 citations in the National Library of Medicine. His published manuscript “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” is the first sequenced, multi-drug early treatment for patients infected with COVID-19. He has 45 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in The Hill.

In November 2020, Dr. McCullough testified to the US Senate Committee on Homeland Security and Governmental Affairs and testified twice in 2021 to the Texas Senate Committee on Health and Human Services concerning early treatment of COVID-19 and many aspects of the pandemic response.

See the Full McCullough Interview Video on Rumble: https://rumble.com/vhp7y5-full-interview-world-renowned-doctor-blows-lid-off-of-covid-vaccine.html

#earlytreatmentworks #earlytreatment #covidtreatment #homepatientguide #texasdoctor #texassenatedoctor #mccullough #hcq #ivermectin #favirpiravir #budesonide #colchicine